Deutsche Bank’s Nephros NEPH Stock Holding History

Deutsche Bank’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200	Closed	-$1K	–	4648
2019 Q4	$1K	Buy	+200	New	+$1.78K	﹤0.01%	4915

Other funds holding NEPH

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's NEPH Position: Q1 2020 in Review

Deutsche Bank sold out of Nephros (NEPH) in Q1 2020, closing a stake of 200 shares — an estimated $1K sold.

Deutsche Bank first reported a position in NEPH in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 21 funds tracked by Wall St. Rank hold NEPH as of Q1 2020.

Deutsche Bank reported no remaining Nephros position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 200 Nephros shares in Q1 2020, an estimated $1K.
Deutsche Bank first reported a position in Nephros in Q4 2019 and held it in 1 quarter.
Deutsche Bank's Nephros position peaked at $1K in Q4 2019.
21 funds tracked by Wall St. Rank held Nephros as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.